Selected sessions on heart failure
Symposium
- HFrEF treatment: where are we and where are we going?
- Treatment of transthyretin amyloidosis cardiomyopathy: on the path to a cure?
- My heart failure patient continues to be symptomatic: 'Stage C2D'
- Breaking the cycle of congestion in heart failure
- Artificial intelligence in heart failure: help or hype?
- Diagnosing HFpEF: who, how, and what?
- The new dangerous liaison: obesity and heart failure
- HFpEF: where are we now and where are we going?
- Concerning trends in global heart failure epidemiology
Late-Breaking science
Guidelines in practice
Hot Line 2
Great Debate
Abstract Sessions
Clinical Cases
Advances in Science
Joint session
Bring your Questions
Our mission: To reduce the burden of cardiovascular disease.